MDMA-induced serotonergic neurotoxicity enhances aggressiveness in low- but not high-aggressive rats

European Journal of Pharmacology

Volumn 618, Issue 1-3, 2009, Pages 22-27

  Wallinga, Alinde E ^a   ten Voorde, Anna M ^a   de Boer, Sietse F ^a   Koolhaas, Jaap M ^a   Buwalda, Bauke ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

3,4 methylenedioxymethamphetamine; Aggressive behavior; Ecstasy; Individual variation; Serotonergic neurotoxicity; Serotonin transporter

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; SEROTONIN; SEROTONIN TRANSPORTER;

AGGRESSION; AGGRESSIVENESS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; ENVIRONMENTAL TEMPERATURE; IMMUNOHISTOCHEMISTRY; MALE; NERVE ENDING; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RAT STRAIN; SEROTONIN RELEASE; SEROTONINERGIC NERVE CELL; WILD TYPE;

AGGRESSION; ANIMALS; BEHAVIOR, ANIMAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; IMMUNOHISTOCHEMISTRY; INDIVIDUALITY; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEURONS; RATS; SEROTONIN; SEROTONIN AGENTS; TIME FACTORS;

EID: 68949189399     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.07.006     Document Type: Article

References (47)

1. Battaglia G., Yeh S.Y., O'Hearn E., Molliver M.E., Kuhar M.J., and De Souza E.B. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites. J.Pharmacol.Exp.Ther. 242 (1987) 911-916
2. Berman M.E., Tracy J.I., and Coccaro E.F. The serotonin hypothesis of aggression revisited. Clin.Psychol.Rev. 17 (1997) 651-665
3. Brown G.L., Ebert M.H., Goyer P.F., Jimerson D.C., Klein W.J., Bunney W.E., and Goodwin F.K. Aggression, suicide, and serotonin: relationships to CSF amine metabolites. Am. J. Psychiatry 139 (1982) 741-746
4. Buchanan C.P., Shrier E.M., and Hill W.L. Time-dependent effects of PCPA on social aggression in chicks. Pharmacol. Biochem. Behav. 49 (1994) 483-488
5. Callahan B.T., Cord B.J., and Ricaurte G.A. Long-term impairment of anterograde axonal transport along fiber projections originating in the rostral raphe nuclei after treatment with fenfluramine or methylenedioxymethamphetamine. Synapse 40 (2001) 113-121
6. Chiavegatto S., Dawson V.L., Mamounas L.A., Koliatsos V.E., Dawson T.M., and Nelson R.J. Brain serotonin dysfunction accounts for aggression in male mice lacking neuronal nitric oxide synthase. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 1277-1281
7. Clark M.S., and Neumaier J.F. The 5-HT1B receptor: behavioral implications. Psychopharmacol. Bull. 35 (2001) 170-185
8. Coccaro E.F. Central serotonin and impulsive aggression. Br. J. Psychiatry Suppl. (1989) 52-62
9. Curran H.V., and Travill R.A. Mood and cognitive effects of +/-3, 4-methylenedioxymethamphetamine (MDMA, 'ecstasy'): week-end 'high' followed by mid-week low. Addiction 92 (1997) 821-831
10. Curran H.V., Rees H., Hoare T., Hoshi R., and Bond A. Empathy and aggression: two faces of ecstasy? A study of interpretative cognitive bias and mood change in ecstasy users. Psychopharmacology (Berl) 173 (2004) 425-433
11. De Almeida R.M., Nikulina E.M., Faccidomo S., Fish E.W., and Miczek K.A. Zolmitriptan-a 5-HT1B/D agonist, alcohol, and aggression in mice. Psychopharmacology (Berl) 157 (2001) 131-141
12. de Boer S.F., van der Vegt B., and Koolhaas J.M. Hypersensitivity of 5-HT1A and 5-HT1B autoreceptors as a possible neuromechanism underlying decreased serotonin neurotransmisstion in excessive aggression. Sociey for neuroscience, 31st Annual Meeting (2001)
13. de Boer S.F., van der Vegt B., and Koolhaas J.M. Individual variation in aggression of feral rodent strains: a standard for the genetics of aggression and violence?. Behav. Genet. 33 (2003) 485-501
14. Gerra G., Zaimovic A., Moi G., Giusti F., Gardini S., Delsignore R., Laviola G., Macchia T., and Brambilla F. Effects of (±) 3, 4-methylene-dioxymethamphetamine (ecstasy) on dopamine system function in humans. Behav. Brain Res. 134 (2002) 403-410
15. Gianutsos G., and Lal H. Aggression in mice after p-chloroamphetamine. Res. Commun. Chem. Pathol. Pharmacol. 10 (1975) 379-382
16. Gibbons J.L., Barr G.A., Bridger W.H., and Leibowitz S.F. Effects of para-chlorophenylalanine and 5-hydroxytryptophan on mouse killing behavior in killer rats. Pharmacol. Biochem. Behav. 9 (1978) 91-98
17. Halasz J., Toth M., Kallo I., Liposits Z., and Haller J. The activation of prefrontal cortical neurons in aggression-a double labeling study. Behav. Brain Res. 175 (2006) 166-175
18. Hewitt K.E., and Green A.R. Chlormethiazole, dizocilpine and haloperidol prevent the degeneration of serotonergic nerve terminals induced by administration of MDMA ('Ecstasy') to rats. Neuropharmacology 33 (1994) 1589-1595
19. Hoshi R., Bisla J., and Curran H.V. The acute and sub-acute effects of 'ecstasy' (MDMA) on processing of facial expressions: preliminary findings. Drug Alcohol Depend. 76 (2004) 297-304
20. Hoshi R., Pratt H., Mehta S., Bond A.J., and Curran H.V. An investigation into the sub-acute effects of ecstasy on aggressive interpretative bias and aggressive mood - are there gender differences?. J. Psychopharmacol. 20 (2006) 291-301
21. Hoshi R., Cohen L., Lemanski L., Piccini P., Bond A., and Curran H.V. Ecstasy (MDMA) does not have long-term effects on aggressive interpretative bias: a study comparing current and ex-ecstasy users with polydrug and drug-naive controls. Exp. Clin. Psychopharmacol. 15 (2007) 351-358
22. Hrabovszky E., Halasz J., Meelis W., Kruk M.R., Liposits Z., and Haller J. Neurochemical characterization of hypothalamic neurons involved in attack behavior: glutamatergic dominance and co-expression of thyrotropin-releasing hormone in a subset of glutamatergic neurons. Neuroscience 133 (2005) 657-666
23. Kelly T.H., Robbins G., Martin C.A., Fillmore M.T., Lane S.D., Harrington N.G., and Rush C.R. Individual differences in drug abuse vulnerability: d-amphetamine and sensation-seeking status. Psychopharmacology (Berl) 189 (2006) 17-25
24. Kirilly E., Benko A., Ferrington L., Ando R.D., Kelly P.A., and Bagdy G. Acute and long-term effects of a single dose of MDMA on aggression in Dark Agouti rats. Int. J. Neuropsychopharmacol. 9 (2006) 63-76
25. Koolhaas J.M., de Boer S.F., Buwalda B., and van Reenen K. Individual variation in coping with stress: a multidimensional approach of ultimate and proximate mechanisms. Brain Behav. Evol. 70 (2007) 218-226
26. Liechti M.E., Gamma A., and Vollenweider F.X. Gender differences in the subjective effects of MDMA. Psychopharmacology (Berl) 154 (2001) 161-168
27. McCann U.D., Ridenour A., Shaham Y., and Ricaurte G.A. Serotonin neurotoxicity after (+/-)3, 4-methylenedioxymethamphetamine (MDMA; "Ecstasy"): a controlled study in humans. Neuropsychopharmacology 10 (1994) 129-138
28. Miczek K.A., Faccidomo S., de Almeida R.M., Bannai M., Fish E.W., and DeBold J.F. Escalated aggressive behavior: new pharmacotherapeutic approaches and opportunities. Ann. N.Y. Acad. Sci. 1036 (2004) 336-355
29. Morgan M.J. Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity. Neuropsychopharmacology 19 (1998) 252-264
30. O'Hearn E., Battaglia G., De Souza E.B., Kuhar M.J., and Molliver M.E. Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity. J. Neurosci. 8 (1988) 2788-2803
31. Parrott A.C. Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research. Hum. Psychopharmacol. 16 (2001) 557-577
32. Parrott A.C., and Lasky J. Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance. Psychopharmacology (Berl) 139 (1998) 261-268
33. Parrott A.C., Sisk E., and Turner J.J. Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users. Drug Alcohol Depend. 60 (2000) 105-110
34. Paxinos, G., Watson, C., 1998. The rat brain in stereotactic coordinates, Academic Press, San Diego.
35. Reid L.W., Elifson K.W., and Sterk C.E. Hug drug or thug drug? Ecstasy use and aggressive behavior. Violence Vict. 22 (2007) 104-119
36. Sanchez V., O'Shea E., Saadat K.S., Elliott J.M., Colado M.I., and Green A.R. Effect of repeated ('binge') dosing of MDMA to rats housed at normal and high temperature on neurotoxic damage to cerebral 5-HT and dopamine neurones. J. Psychopharmacol. 18 (2004) 412-416
37. Schmidt C.J., and Taylor V.L. Depression of rat brain tryptophan hydroxylase activity following the acute administration of methylenedioxymethamphetamine. Biochem. Pharmacol. 36 (1987) 4095-4102
38. Semple S.J., Zians J., Grant I., and Patterson T.L. Impulsivity and methamphetamine use. J. Subst. Abuse Treat. 29 (2005) 85-93
39. Sharkey J., McBean D.E., and Kelly P.A. Alterations in hippocampal function following repeated exposure to the amphetamine derivative methylenedioxymethamphetamine ("Ecstasy"). Psychopharmacology (Berl) 105 (1991) 113-118
40. Sijbesma H., Schipper J., de Kloet E.R., Mos J., van A.H., and Olivier B. Postsynaptic 5-HT1 receptors and offensive aggression in rats: a combined behavioural and autoradiographic study with eltoprazine. Pharmacol. Biochem. Behav. 38 (1991) 447-458
41. Stone D.M., Stahl D.C., Hanson G.R., and Gibb J.W. The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain. Eur. J. Pharmacol. 128 (1986) 41-48
42. Stone D.M., Johnson M., Hanson G.R., and Gibb J.W. A comparison of the neurotoxic potential of methylenedioxyamphetamine (MDA) and its N-methylated and N-ethylated derivatives. Eur. J. Pharmacol. 134 (1987) 245-248
43. Vergnes M., Depaulis A., and Boehrer A. Parachlorophenylalanine-induced serotonin depletion increases offensive but not defensive aggression in male rats. Physiol. Behav. 36 (1986) 653-658
44. Verheyden S.L., Hadfield J., Calin T., and Curran H.V. Sub-acute effects of MDMA (+/-3, 4-methylenedioxymethamphetamine, "ecstasy") on mood: evidence of gender differences. Psychopharmacology (Berl) 161 (2002) 23-31
45. Vollenweider F.X., Gamma A., Liechti M., and Huber T. Psychological and cardiovascular effects and short-term sequelae of MDMA ("ecstasy") in MDMA-naive healthy volunteers. Neuropsychopharmacology 19 (1998) 241-251
46. White T.L., Lott D.C., and de W.H. Personality and the subjective effects of acute amphetamine in healthy volunteers. Neuropsychopharmacology 31 (2006) 1064-1074
47. Xie T., Tong L., McLane M.W., Hatzidimitriou G., Yuan J., McCann U., and Ricaurte G. Loss of serotonin transporter protein after MDMA and other ring-substituted amphetamines. Neuropsychopharmacology 31 (2006) 2639-2651